Bayer CropScience Ltd Q2 FY26 results (latest), Jul–Sep 2025 →Revenue ₹1,553 Cr −10.6% YoYSee revenue, profit and what management said. You are viewing Q2 FY20.
BC

Bayer CropScience Ltd

Q2 FY20Fertilizers & Agrochemicals

Bayer CropScience Q2 FY20 earnings call: Revenue & Margins

Q2 FY20 investor presentation: what the company reported on revenue, margins and capex.

Bayer CropScience Ltd Q2 FY20 key numbers

Revenue
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase.

As stated in Bayer CropScience Ltd's Q2 FY20 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Bayer CropScience Ltd's Q2 FY20 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹3,736
Market cap₹17.0K Cr
P/E23.2

The short version

Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY

From Bayer CropScience Ltd's Q2 FY20 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20).
  • H1 Revenue from Operations: ₹22,967 million, +7.3% year-on-year growth (Page 20).
  • Q2 Profit Before Exceptional Items and Tax: ₹4,978 million, +1.3% year-on-year (Page 20).
  • H1 Profit Before Exceptional Items and Tax: ₹4,913 million, +22.2% year-on-year (Page 20).
  • Sept YTD EverGol Xtend & Velum Prime sales: 17 KL with a full-year estimate of 23 KL (Page 24).
  • Arize business milestone: volume achieved 15,570 MT (Page 23).

2 more points from Bayer CropScience Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Bayer CropScience Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Key highlights include: - Growth in Q2 with 9% positive trend (page 25). - Successful completion of legal merger and ongoing integration (page 25). - Business highlights such as product launches, sales performance, and inventory management, but no direct references to order book or pending orders (pages 23-25).

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Aries Agro (Q2 FY20)

    EBITDA: INR 450 million (H1-FY20) with margin 16.96% (FY19 full year). Key concall takeaways from Aries Agro Ltd's Q2 FY20 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bayer CropScience Ltd Q2 FY20 results?

Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.